Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Jason Tregellas to Antipsychotic Agents

This is a "connection" page, showing publications Jason Tregellas has written about Antipsychotic Agents.

 
Connection Strength
 
 
 
1.600
 
  1. Dodd K, Legget KT, Cornier MA, Novick AM, McHugo M, Berman BD, Lawful BP, Tregellas JR. Relationship between functional connectivity and weight-gain risk of antipsychotics in schizophrenia. Schizophr Res. 2024 05; 267:173-181.
    View in: PubMed
    Score: 0.769
  2. Tregellas JR. Neuroimaging biomarkers for early drug development in schizophrenia. Biol Psychiatry. 2014 Jul 15; 76(2):111-9.
    View in: PubMed
    Score: 0.372
  3. Smucny J, Tregellas J. Nicotinic modulation of intrinsic brain networks in schizophrenia. Biochem Pharmacol. 2013 Oct 15; 86(8):1163-72.
    View in: PubMed
    Score: 0.365
  4. Smucny J, Stevens KE, Tregellas JR. Acute administration of ?? tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice. Pharmacol Biochem Behav. 2014 Mar; 118:22-9.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)